Literature DB >> 1186714

Proceedings: Cytogenetic testing of antiepileptic drugs in human patients.

H D Bartsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1186714     DOI： 10.1016/0027-5107(75)90170-0

Source DB:  PubMed          Journal:  Mutat Res        ISSN： 0027-5107            Impact factor:   2.433


× No keyword cloud information.
  5 in total

1.  Increased chromosomal breakage in epileptic children after long-term treatment.

Authors:  P Curatolo; V Brinchi; R Cusmai; P Vignetti; P Benedetti
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

2.  Chromosomal investigations in children with pyknolepsy on dipropylacetate monotherapy.

Authors:  F Kotlarek; J Faust
Journal:  Hum Genet       Date:  1978-09-19       Impact factor: 4.132

3.  Chromosome fragile sites in mentally retarded males: increased incidence with seizures and diphenylhydantoin therapy.

Authors:  K B Hodges; R S Larson; M G Butler
Journal:  Ann Clin Lab Sci       Date:  1998 Sep-Oct       Impact factor: 1.256

4.  Chromosomal investigations in epileptic children during long-term therapy with phenytoin or primidone.

Authors:  K J Esser; F Kotlarek; M Habedank; U Mühler; E Mühler
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

5.  Chromosomal damage in epileptics on monotherapy with carbamazepine and diphenylhydantoin.

Authors:  J Herha; G Obe
Journal:  Hum Genet       Date:  1976-12-15       Impact factor: 4.132
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.